Results 21 to 30 of about 283,903 (204)

Knowledge, Awareness and Risk of Occurrence of Venous Thromboembolism of Perinatal Women [PDF]

Korean Journal of Women Health Nursing, 2019
PURPOSE: The purpose of this study is to identify knowledge, awareness, and risk of occurrence of venous thromboembolism among pregnant women. METHODS: Subjects were 106 pregnant women treated as inpatients and outpatients at a women's health ...
Eun Sook Kim, Hye Young Kim
doaj   +1 more source

Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database

Drugs - Real World Outcomes, 2023
Background Approximately a decade has passed since the addition of venous thromboembolism to the list of significant adverse reactions of antipsychotic drugs.
Hiroyuki Hashimoto, Shinobu Imai, Ryoka Yamashita, Anna Kiyomi, Munetoshi Sugiura   +4 more
doaj   +1 more source

Venous thromboembolism

Journal of Postgraduate Medicine, 2009
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow described the famous Virchow's triad in 1856, there have been rapid strides in the understanding of the pathogenesis and factors responsible for it. Discovery of various thrombophilic factors, both primary and acquired, in the last
Dutta, T.K., Venugopal, V.
openaire   +4 more sources

Omalizumab as a Provoking Factor for Venous Thromboembolism

Drug Target Insights, 2019
A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain ...
Crhistian-Mario Oblitas, Francisco Galeano-Valle, Laura Vela-De La Cruz, Jorge Del Toro-Cervera, Pablo Demelo-Rodríguez   +4 more
doaj   +1 more source

DEEP VEIN THROMBOSIS AND RECURENT PULMONARY EMBOLISM IN A PATIENT WITH THROMBOPHILIC MUTATIONS AND GENERALIZED PSORIASIS: A CASE REPORT

Sanamed, 2020
Introduction: Genetic risk factors that increase venous thromboembolism risk are disorders in the synthesis or activity of coagulation factors. Factor V Leiden, prothrombin (20210-A), antithrombin deficiency, protein C and protein S deficiency, and ...
Marjan Nove Baloski, Daniela Buklioska Ilievska, Vesna Brishkovska-Boshkovski, Taner Hasan, Natasa Nedeska Minova, Biljana Prgova-Veljanova, Andrea Nanceva Bogoevska, Jasminka Nanceva, Marijan Bosevski, Sasho Panov   +9 more
doaj   +1 more source

Electronic health record risk-stratification tool reduces venous thromboembolism events in surgical patients

Surgery Open Science, 2022
Background: Venous thromboembolism is a preventable cause of morbidity and mortality after surgery. To ensure that patients receive appropriate venous thromboembolism chemoprophylaxis, a nonmandatory risk-stratification tool based on patient clinical ...
Radhika Rastogi, MD, Courtney M. Lattimore, MD, J. Hunter Mehaffey, MD, MSc, Florence E. Turrentine, PhD, RN, Hillary S. Maitland, MD, MS, Victor M. Zaydfudim, MD, MPH   +5 more
doaj   +1 more source

Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) [PDF]

, 2011
<p>Background: Venous thromboembolic events (VTE), including deep venous thrombosis and pulmonary embolism, are common in older age. It has been suggested that statins might reduce the risk of VTE however positive results from studies of middle ...
Frölich Marijke, Marijke Frölich, Frölich, Margaret, Brown, E.A., Jukema J Wouter, Anton JM de Craen, Ford Ian, Ian Ford, Frolich, M., E Ann Brown, Slagboom, P. Eline, Freeman Dilys J, Greer Ian A, Ann Rumley, Rumley, A., David J Stott, Tobias, E.S., Greer, I.A., Slagboom P Eline, Ian A Greer, Gordon DO Lowe, Stott David J, P Eline Slagboom, Greer, Ian A., Craen, A.J.M. de, de Craen, Anton J.M., Rumley, Ann, Allan Gaw, Freeman, D.J., Tobias, Edward S., Naveed Sattar, Ford, Ian, Brown E Ann, Gaw, A., Jukema, J.W., Lowe, G.D.O., Dilys J Freeman, Freeman, Dilys J., Sattar, N., Jukema, J. Wouter, Lowe, Gordon D.O., Ford, I., Robertson, Michele, Sattar Naveed, Slagboom, P.E., Robertson, M., de Craen Anton JM, Robertson Michele, Brown, E. Ann, Michele Robertson, Tobias Edward S, J Wouter Jukema, Sattar, Naveed, Stott, David J., Gaw, Allan, Rumley Ann, Lowe Gordon DO, Edward S Tobias, Stott, D.J., Gaw Allan   +59 more
core   +2 more sources

Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update

Pharmaceutics
Direct oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed
Anabel Franco-Moreno, Elena Madroñal-Cerezo, Ana Martínez-Casa-Muñoz, Judith Ortiz-Sánchez, Cristina Lucía Ancos-Aracil   +4 more
doaj   +1 more source

Epidemiology and pathophysiology of cancer-associated thrombosis [PDF]

, 2010
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. First recognised by Bouillard in 1823 and later described by Trousseau in 1844, multiple studies have since provided considerable evidence for a clinical ...
Pasi, J, S Noble, J Pasi, Noble, Simon Ian Robert, Pasi, J., Noble, S   +5 more
core   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Erhard Hiller, Hiller, Erhard
core   +1 more source